These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 31419167

  • 1. A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine.
    Gou X, Wu X, Shi Y, Zhang K, Huang J.
    Hum Vaccin Immunother; 2020; 16(2):286-294. PubMed ID: 31419167
    [Abstract] [Full Text] [Related]

  • 2. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855
    [Abstract] [Full Text] [Related]

  • 3. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
    Zhang L, Jia N, Li J, Han Y, Cao W, Wang S, Huang Z, Lu S.
    Hum Vaccin Immunother; 2014 Oct 15; 10(7):1949-58. PubMed ID: 25424804
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
    Meseda CA, Atukorale V, Soto J, Eichelberger MC, Gao J, Wang W, Weiss CD, Weir JP.
    Sci Rep; 2018 Mar 29; 8(1):5364. PubMed ID: 29599502
    [Abstract] [Full Text] [Related]

  • 6. An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.
    Krammer F, Jul-Larsen A, Margine I, Hirsh A, Sjursen H, Zambon M, Cox RJ.
    Clin Vaccine Immunol; 2014 Aug 29; 21(8):1153-63. PubMed ID: 24943383
    [Abstract] [Full Text] [Related]

  • 7. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.
    Rudenko L, Isakova-Sivak I, Donina S.
    Vaccine; 2013 Oct 01; 31(42):4702-5. PubMed ID: 23988294
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI, Kim YI, Park SJ, Song MS, Kim EH, Kim SM, Si YJ, Lee IW, Song BM, Lee YJ, Yun SJ, Kim WJ, Choi YK.
    J Virol; 2017 Jun 01; 91(11):. PubMed ID: 28331080
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses.
    Guo L, Wang D, Zhou H, Wu C, Gao X, Xiao Y, Ren L, Paranhos-Baccalà G, Shu Y, Jin Q, Wang J.
    Sci Rep; 2016 Feb 24; 6():22045. PubMed ID: 26907865
    [Abstract] [Full Text] [Related]

  • 12. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
    Wang Y, Lv Y, Niu X, Dong J, Feng P, Li Q, Xu W, Li J, Li C, Li J, Luo J, Li Z, Liu Y, Tan YJ, Pan W, Chen L.
    J Virol; 2020 Sep 29; 94(20):. PubMed ID: 32796071
    [Abstract] [Full Text] [Related]

  • 13. AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes.
    Mallett CP, Beaulieu E, Joly MH, Baras B, Lu X, Liu F, Levine MZ, Katz JM, Innis BL, Giannini SL.
    Vaccine; 2015 Jul 31; 33(32):3784-7. PubMed ID: 26100923
    [Abstract] [Full Text] [Related]

  • 14. Divergent H7 immunogens offer protection from H7N9 virus challenge.
    Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, García-Sastre A, Palese P.
    J Virol; 2014 Apr 31; 88(8):3976-85. PubMed ID: 24453375
    [Abstract] [Full Text] [Related]

  • 15. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
    Andersen TK, Zhou F, Cox R, Bogen B, Grødeland G.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931687
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
    Schmeisser F, Vasudevan A, Verma S, Wang W, Alvarado E, Weiss C, Atukorale V, Meseda C, Weir JP.
    PLoS One; 2015 Dec 01; 10(1):e0117108. PubMed ID: 25629172
    [Abstract] [Full Text] [Related]

  • 17. Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.
    Stadlbauer D, Amanat F, Strohmeier S, Nachbagauer R, Krammer F.
    Emerg Microbes Infect; 2018 Jun 20; 7(1):110. PubMed ID: 29925896
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
    Criado MF, Bertran K, Lee DH, Killmaster L, Stephens CB, Spackman E, Sa E Silva M, Atkins E, Mebatsion T, Widener J, Pritchard N, King H, Swayne DE.
    Vaccine; 2019 Apr 10; 37(16):2232-2243. PubMed ID: 30885512
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.
    Alvarado-Facundo E, Vassell R, Schmeisser F, Weir JP, Weiss CD, Wang W.
    PLoS One; 2016 Apr 10; 11(2):e0149149. PubMed ID: 26862918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.